Treat FTD Fund
Funds early-stage clinical studies for frontotemporal dementia, including prevention trials for high-risk participants.
The Treat FTD Fund is a joint clinical-trials funding program operated by the Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD), addressing the critical shortage of interventional studies for frontotemporal degeneration disorders — a rare disease cluster affecting approximately 50,000 to 60,000 Americans with no approved disease-modifying treat…
Phase 0, 1, or 2 clinical trials for frontotemporal degeneration disorders. Prevention trials in presymptomatic at-risk individuals also eligible. IND-enabling work must be completed or near-complete.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
Write proposalGrant Concept Note Example: Pre-Proposal Structure for Startups
See a practical grant concept note example, with a worked deeptech pre-proposal, section map, invite-to-full logic, and reviewer checks.
More from ADDF
All grants from this funder →ADDF Drug Development RFP
ADDF · Global / Multinational
Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.
ADDF Neuroimaging and CSF Biomarker RFP
ADDF · Global / Multinational
Funds new biomarkers for Alzheimer's and related dementias through PET ligands, MRI, spinal fluid, and brain activity measures.
ADDF Prevention RFP
ADDF · Global / Multinational
Supports dementia prevention research through precision risk reduction, combination treatment testing, and effectiveness comparisons.
ADDF-Harrington Scholar Program
🇺🇸ADDF · Global / Multinational
Funds academic Alzheimer's researchers with hit-to-lead and development-stage support plus therapeutic guidance.
Accelerating Drug Discovery for FTD RFP
ADDF · Global / Multinational
Funds lead optimization and in vivo testing for frontotemporal dementia candidates, including medicinal chemistry and preclinical studies.
Similar grants
Browse the directory →
CFI College Fund
🇨🇦CFI · Canada
Funds the Canada Foundation for Innovation College Fund grants for Canadian colleges building research infrastructure and commercialization-ready outputs.
NRF Central Gap Fund
🇸🇬NRF Singapore · Singapore
Funds translational technologies in Singapore through the NRF Central Gap Fund toward prototype development.
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.
Research Ireland Frontiers for the Future
🇮🇪Research Ireland · Ireland
Funds high-risk investigator-driven research in Ireland across frontier technology and translational discovery.
NIH SBIR Fast-Track (Omnibus)
🇺🇸NIH · United States
Supports United States small businesses with streamlined biomedical pathways from feasibility to continued development.
NSF SBIR/STTR Fast-Track Pilot
🇺🇸NSF · United States
Supports United States deep-tech startups through a combined early and continuation development route.